World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
50119
World Ranking
5513
National Ranking
2972

Mikhail V. Blagosklonny publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mikhail V. Blagosklonny sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 274 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mikhail V. Blagosklonny D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mikhail V. Blagosklonny sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mikhail V. Blagosklonny is affiliated with the Roswell Park Cancer Institute in the United States. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, Medicine, and Neuroscience, with a total of 28, 24, and 13 publications respectively in these areas. Subfields of study reflect a focus on Aging, Molecular Biology, Physiology, Endocrine and Autonomic Systems, and Oncology.

The scientist's work covers main topics such as Genetics, Aging, and Longevity in Model Organisms, Circadian rhythm and melatonin, Dietary Effects on Health, PI3K/AKT/mTOR signaling in cancer, Telomeres, Telomerase, and Senescence, Lung Cancer Treatments and Mutations, and Cancer-related Molecular Pathways.

Frequent publication venues for their research include Aging, Oncotarget, Oncoscience, Cell Death and Differentiation, and Cell Cycle. The volume of publications is highest in Aging with 9, followed by 5 publications each in Oncotarget and Oncoscience, and one publication each in Cell Death and Differentiation and Cell Cycle.

Recent papers authored by Mikhail V. Blagosklonny include:

  • From causes of aging to death from COVID-19 (2020), Aging
  • Cancer prevention with rapamycin (2023), Oncotarget
  • Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells (2023), Oncotarget
  • Cell senescence, rapamycin and hyperfunction theory of aging (2022), Cell Cycle

Other recent influential papers by collaborators include "Apoptotic cell death in disease-Current understanding of the NCCD 2023" (2023) published in Cell Death and Differentiation.

Frequent co-authors working with Mikhail V. Blagosklonny include Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, and John Abrams. These collaborations contribute to the multidisciplinary nature of their research.

Best Publications

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

    G. Kroemer;G. Kroemer;G. Kroemer;L. Galluzzi;L. Galluzzi;L. Galluzzi;P. Vandenabeele;J. Abrams

  • Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

    Galluzzi L;Vitale I;Vitale I;Vitale I;Abrams Jm;Alnemri Es

  • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

    L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  • Stabilization of wild-type p53 by hypoxia-inducible factor 1α

    W G An;M Kanekal;M C Simon;E Maltepe

  • Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

    L. Galluzzi;L. Galluzzi;L. Galluzzi;S. A. Aaronson;J. Abrams;E. S. Alnemri

  • Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

    Victor Sandor;Susan Bakke;Robert W Robey;Min H Kang

  • The Restriction Point of the Cell Cycle

    Mikhail V. Blagosklonny;Arthur B. Pardee

  • Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association

    Theodor W. Schulte;Mikhail V. Blagosklonny;Christian Ingui;Len Neckers

  • Taxol-induced Apoptosis and Phosphorylation of Bcl-2 Protein Involves c-Raf-1 and Represents a Novel c-Raf-1 Signal Transduction Pathway

    Mikhail V. Blagosklonny;Theodor Schulte;Phuongmai Nguyen;Jane Trepel

  • Raf-1/bcl-2 Phosphorylation: A Step from Microtubule Damage to Cell Death

    Mikhail V. Blagosklonny;Paraskevi Giannakakou;Wafik S. El-Deiry;David G. I. Kingston

  • Molecular effects of paclitaxel: myths and reality (a critical review).

    Mikhail V. Blagosklonny;Tito Fojo

  • Growth stimulation leads to cellular senescence when the cell cycle is blocked

    Zoya N. Demidenko;Mikhail V Blagosklonny

  • p53 is associated with cellular microtubules and is transported to the nucleus by dynein.

    Paraskevi Giannakakou;Dan L. Sackett;Yvona Ward;Kevin R. Webster

  • Rapamycin decelerates cellular senescence

    Zoya N. Demidenko;Svetlana G. Zubova;Elena I. Bukreeva;Valery A. Pospelov

  • Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.

    Mikhail V Blagosklonny

  • p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription *

    Mikhail V. Blagosklonny;Won G. An;Larisa Y. Romanova;Jane Trepel

  • P21-dependent G 1 arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228

    V Sandor;A Senderowicz;S Mertins;D Sackett

  • Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.

    T W Schulte;M V Blagosklonny;L Romanova;J F Mushinski

  • Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice.

    Vladimir N Anisimov;Mark A Zabezhinski;Irina G Popovich;Tatiana S Piskunova

Frequent Co-Authors

Tito Fojo
Tito Fojo Columbia University
Wafik S. El-Deiry
Wafik S. El-Deiry Brown University
Andrei V. Gudkov
Andrei V. Gudkov Roswell Park Cancer Institute
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Gerry Melino
Gerry Melino University of Rome Tor Vergata
Zbigniew Darzynkiewicz
Zbigniew Darzynkiewicz New York Medical College
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Susan E. Bates
Susan E. Bates Columbia University
Peter Vandenabeele
Peter Vandenabeele Ghent University
Sharad Kumar
Sharad Kumar University of Adelaide

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens up various related online degree options and flexible career pathways in healthcare. If you are interested in patient care but prefer a route other than traditional pre-med tracks, consider exploring nursing schools that don't require teas or hesi. These programs offer opportunities for aspiring nurses to enter the field without some of the standard testing requirements.

For those leaning toward the administrative side of healthcare, accredited healthcare administration degree programs provide essential training in policy, management, and business. These degrees are ideal if you're interested in the strategic, policy, or leadership aspects of healthcare.

Already an RN? Transitioning to rewarding advanced roles is possible with adn to fnp programs, which allow you to become a family nurse practitioner through accelerated pathways designed for working nurses.

Additionally, if you’re passionate about wellness, food science, or preventive care, a nutritionist online degree can open doors in clinical nutrition, public health, or private practice.

Best Scientists Citing Mikhail V. Blagosklonny

Trending Scientists

Recently Published Articles